Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C

Published:2016-07 Issue:1 Volume:65 Page:40-47
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Desnoyer Aude,Pospai Dan,Lê Minh Patrick,Gervais Anne,Heurgué-Berlot Alexandra,Laradi Achour,Harent Stanislas,Pinto Adriana,Salmon Dominique,Hillaire Sophie,Fontaine Hélène,Zucman David,Simonpoli Anne-Marie,Muret Patrice,Larrouy Lucile,Bernard Chabert Brigitte,Descamps Diane,Yazdanpanah Yazdan,Peytavin Gilles

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;J Hepatol,2014

2. Hepatitis C virus and kidney disease;Martin;J Hepatol,2008

3. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease;Chen;Kidney Int,2014

4. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis;Lee;PLoS One,2014

5. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans;Molnar;Hepatology,2015

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

2. Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection;Clinical and Translational Science;2024-07

3. Efficacy of Sofosbuvir and Velpatasvir Combination in the Treatment of Hepatitis C Virus (HCV) in Chronic Kidney Disease (CKD) Patients;Cureus;2024-05-22

4. Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study;The Korean Journal of Internal Medicine;2023-07-01

5. Chronic Hepatitis C Virus Infection in Chronic Kidney Disease;Hepatitis C - Recent Advances;2023-05-15